Simon Ducher serves as the Vice President and Head of Regulatory Affairs at BlueJay Therapeutics since August 2022, focusing on developing cures for infectious diseases such as chronic hepatitis B and D. In addition, Simon has been an Investor (LP) at Quake Capital Partners since February 2018, contributing to a top-performing seed stage venture capital fund recognized for its diversity in investments. Prior to their current roles, Simon was the Chief Regulatory Officer at Seneque, and held multiple senior positions at Progenics Pharmaceuticals, Inc., concluding as Senior Director of Regulatory Affairs. Simon's extensive background in global regulatory affairs was further established through prior roles at Novartis and a clinical research fellowship at CHU de Clermont-Ferrand. Educational qualifications include a PharmD from UNIVERSITE D'AUVERGNE and a Master’s degree in International Drug Development and Registration from Paris-Sud University.
This person is not in the org chart
This person is not in any teams